%0 Journal Article
%T Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose- and time-dependent manner
%A Lohmeyer, J
%A Nerreter, T
%A Dotterweich, J
%A Einsele, H
%A Seggewiss-Bernhardt, R
%J Clinical & Experimental Immunology
%V 193
%N 1
%P 64-72
%@ 0009-9104
%D 2018-07-10
%I Oxford University Press
%~ DeepDyve